Court Revives Zicam Complaint, But Says Disclosure Remains Case-by-Case

An appellate court decision supporting a complaint against Matrixx Initiatives related to its over-the-counter cold remedy Zicam shows that determining what information firms must disclose is a "delicate," case-by-case process